The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma

<div>EAM protocol scheme at glance. Preharvested autologous stem cells were infused after 1 full day rest without chemotherapy (day zero). BMT, bone marrow transplantation; PBSC, peripheral blood stem cell.</div>

Case Reports in Hematology

fig3

Figure 3

Figure 3: The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma 

Figure 3 | The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma 